Literature DB >> 1628630

Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines.

A Ma1, P Fisher, R Dildrop, E Oltz, G Rathbun, P Achacoso, A Stall, F W Alt.   

Abstract

Transgenic mice carrying either the c-myc or N-myc oncogene deregulated by the immunoglobulin heavy chain enhancer element (E mu) develop both pre-B and B cell lymphomas (E mu-c-myc and E mu-N-myc lymphomas). We report here that B cell lines derived from these tumors, as well as a line derived from v-myc retroviral transformation, simultaneously express surface immunoglobulin (a hallmark of mature B cells) as well as a common subset of genes normally restricted to the pre-B stage of development-including the recombinase activating genes RAG-1 and RAG-2. Continued RAG-1 and RAG-2 expression in these lines is associated with VDJ recombinase activity detected with a VDJ recombination substrate. Cross-linking of the surface immunoglobulin on these lines with an anti-mu antibody leads to rapid, specific and reversible down-regulation of RAG-1 and RAG-2 gene expression. We also find that a small but significant percentage of normal surface immunoglobulin bearing bone marrow B cells express the RAG-1 gene. These findings are discussed in the context of their possible implications for the control of specific gene expression during the pre-B to B cell transition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628630      PMCID: PMC556748          DOI: 10.1002/j.1460-2075.1992.tb05338.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Transcriptional down-regulation of N-myc expression during B-cell development.

Authors:  R K Smith; K Zimmerman; G D Yancopoulos; A Ma; F W Alt
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  A simple technique for generating probes for RNA in situ hybridization: an adjunct to genome mapping exemplified by the RAG-1/RAG-2 gene cluster.

Authors:  T Boehm; R Gonzalez-Sarmiento; M Kennedy; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking.

Authors:  L A Turka; D G Schatz; M A Oettinger; J J Chun; C Gorka; K Lee; W T McCormack; C B Thompson
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

Review 4.  Molecular and cellular origins of B lymphocyte diversity.

Authors:  A Rolink; F Melchers
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

5.  Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice.

Authors:  D L Vaux; J M Adams; W S Alexander; B L Pike
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

6.  Sequence-specific DNA binding by the c-Myc protein.

Authors:  T K Blackwell; L Kretzner; E M Blackwood; R N Eisenman; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

7.  Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors.

Authors:  A Ma; R K Smith; A Tesfaye; P Achacoso; R Dildrop; N Rosenberg; F W Alt
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

8.  The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system.

Authors:  J J Chun; D G Schatz; M A Oettinger; R Jaenisch; D Baltimore
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

9.  IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.

Authors:  T Möröy; P Fisher; C Guidos; A Ma; K Zimmerman; A Tesfaye; R DePinho; I Weissman; F W Alt
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  19 in total

1.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  RAG2 is regulated differentially in B and T cells by elements 5' of the promoter.

Authors:  R J Monroe; F Chen; R Ferrini; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras.

Authors:  A C Shaw; W Swat; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes.

Authors:  Laurent Verkoczy; Djemel Aït-Azzouzene; Patrick Skog; Annica Märtensson; Julie Lang; Bao Duong; David Nemazee
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

6.  Cloning and functional characterization of the early-lymphocyte-specific Pb99 gene.

Authors:  B P Sleckman; W N Khan; W Xu; C H Bassing; B A Malynn; N G Copeland; C G Bardon; T M Breit; L Davidson; E M Oltz; N A Jenkins; J E Berman; F W Alt
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

7.  Further investigation of the light chain shifting phenomenon: light chain replacement through secondary rearrangement induced by lectin stimulation in the hybridoma cell line HB4C5.

Authors:  C Krungkasem; K Ueda; H Tachibana; S Shirahata
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

8.  Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.

Authors:  S K Srinivas; J W Sixbey
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Authors:  J Ludovic Croxford; Melissa Li Fang Tang; Meng Fei Pan; Caleb Weihao Huang; Neha Kamran; Cindy Meow Ling Phua; Wee Joo Chng; Siok Bian Ng; David H Raulet; Stephan Gasser
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

10.  Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.

Authors:  Li Bai; Yuhong Chen; Yinghong He; Xuezhi Dai; Xueyan Lin; Renren Wen; Demin Wang
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.